发明名称 |
TITRATION DOSING REGIMEN FOR CONTROLLED RELEASE TRAMADOL |
摘要 |
<P>PROBLEM TO BE SOLVED: To provide a dosing regimen for controlled release tramadol significantly reducing the occurrence of and concomitant severity of harmful adverse tramadol elicited side effects. <P>SOLUTION: The dosage regimen includes administering: about 75 mg to about 125 mg of tramadol in a controlled release dosage form once-a-day, for about 4 to about 10 days; then about 175 mg to about 225 mg of tramadol in a controlled release dosage form once-a-day for about 4 to about 10 days; and then about 275 mg to about 325 mg of tramadol in a controlled release dosage form once-a-day for at least 1 day and optionally thereafter. <P>COPYRIGHT: (C)2012,JPO&INPIT |
申请公布号 |
JP2011225592(A) |
申请公布日期 |
2011.11.10 |
申请号 |
JP20110137231 |
申请日期 |
2011.06.21 |
申请人 |
EURO-CELTIQUE SA |
发明人 |
CURTIS WRIGHT;COLUCCI ROBERT M;SANCHEZ RAYMOND |
分类号 |
A61K31/135;A61K9/20;A61K9/28;A61P25/04;A61P29/02 |
主分类号 |
A61K31/135 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|